S. L. Greenspan

6.0k total citations · 1 hit paper
73 papers, 4.0k citations indexed

About

S. L. Greenspan is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, S. L. Greenspan has authored 73 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Orthopedics and Sports Medicine, 41 papers in Oncology and 14 papers in Surgery. Recurrent topics in S. L. Greenspan's work include Bone health and osteoporosis research (50 papers), Bone health and treatments (38 papers) and Bone and Joint Diseases (16 papers). S. L. Greenspan is often cited by papers focused on Bone health and osteoporosis research (50 papers), Bone health and treatments (38 papers) and Bone and Joint Diseases (16 papers). S. L. Greenspan collaborates with scholars based in United States, Japan and France. S. L. Greenspan's co-authors include Kenneth G. Saag, Ethel S. Siris, Andrea Singer, E. Michael Lewiecki, Meryl S. LeBoff, Harold N. Rosen, Karl Insogna, A C Moses, Rivka Dresner–Pollak and Steve E. Humphries and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

S. L. Greenspan

72 papers receiving 3.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The clinician’s guide to prevention and treatment of osteoporosis

2022 623 citations Meryl S. LeBoff, S. L. Greenspan et al. Osteoporosis International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. L. Greenspan United States	34	2.6k	1.6k	1.2k	756	446	73	4.0k
Ewa Marcinowska-Suchowierska Poland	12	2.8k 1.1×	2.1k 1.3×	1.7k 1.4×	773 1.0×	990 2.2×	60	4.6k
Susan Randall United States	13	3.0k 1.2×	1.2k 0.7×	1.2k 1.0×	1.5k 1.9×	616 1.4×	16	4.6k
Stefano Gonnelli Italy	37	2.8k 1.1×	1.2k 0.7×	1.2k 1.0×	930 1.2×	828 1.9×	189	4.9k
René Rizzoli Switzerland	31	2.4k 0.9×	1.0k 0.6×	1.1k 1.0×	1.1k 1.5×	605 1.4×	78	4.7k
Joan McGowan United States	19	1.6k 0.6×	1.3k 0.8×	1.1k 1.0×	882 1.2×	280 0.6×	30	3.5k
G. P. Dalsky United States	29	2.8k 1.1×	1.4k 0.9×	1.2k 1.0×	626 0.8×	354 0.8×	52	5.0k
P.D. Delmas France	32	2.6k 1.0×	1.7k 1.1×	1.5k 1.2×	852 1.1×	930 2.1×	56	5.5k
Marius Kraenzlin Switzerland	34	1.2k 0.5×	779 0.5×	884 0.8×	876 1.2×	431 1.0×	90	3.6k
Sherri‐Ann M. Burnett‐Bowie United States	32	1.7k 0.7×	1.4k 0.8×	1.3k 1.1×	608 0.8×	639 1.4×	78	4.3k
C. Mautalén Argentina	37	3.3k 1.3×	2.0k 1.2×	1.0k 0.9×	1.5k 2.0×	734 1.6×	160	5.6k

Countries citing papers authored by S. L. Greenspan

Since Specialization

Citations

This map shows the geographic impact of S. L. Greenspan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. L. Greenspan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. L. Greenspan more than expected).

Fields of papers citing papers by S. L. Greenspan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. L. Greenspan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. L. Greenspan. The network helps show where S. L. Greenspan may publish in the future.

Co-authorship network of co-authors of S. L. Greenspan

This figure shows the co-authorship network connecting the top 25 collaborators of S. L. Greenspan. A scholar is included among the top collaborators of S. L. Greenspan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. L. Greenspan. S. L. Greenspan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

LeBoff, Meryl S., S. L. Greenspan, Karl Insogna, et al.. (2022). The clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International. 33(10). 2049–2102. 623 indexed citations breakdown →

Papapoulos, Socrates E., DW Dempster, J. A. Eisman, et al.. (2013). Phase 3 Fracture Trial Of Odanacatib For Osteoporosis - Baseline Characteristics and Study Design. Osteoporosis International. 24. 3 indexed citations

Nayak, Smita, et al.. (2013). Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review. Osteoporosis International. 25(1). 23–49. 38 indexed citations

Dempster, David W., J. A. Eisman, S. L. Greenspan, et al.. (2010). Phase 3 Fracture Trial of Odanacatib for Osteoporosis - Study Design. Endocrine Reviews. 31(3). 1 indexed citations

Cosman, Felicia, E.F. Eriksen, Christopher Recknor, et al.. (2010). Effects of once-yearly zoledronic acid 5mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis. Bone. 47. S55–S56. 2 indexed citations

Perera, Subashan, et al.. (2009). Risedronatın kalçanın yapısal geometrisi üzerine etkisi: Kemoterapi ile indüklenmiş menopoz sonrası kadınlarda yapılan bir yıl süreli çift-kör bir klinik çalışma. Bone. 1(2). 77–85. 1 indexed citations

Londen, G. J. van, Subashan Perera, Priya Rastogi, et al.. (2009). Changes in body composition in women with breast cancer on aromatase inhibitors: A two-year trial. Journal of Clinical Oncology. 27(15_suppl). 9528–9528. 1 indexed citations

Nayak, Smita, Mark S. Roberts, & S. L. Greenspan. (2009). Factors associated with diagnosis and treatment of osteoporosis in older adults. Osteoporosis International. 20(11). 1963–1967. 23 indexed citations

Sellmeyer, Deborah E., Dennis M. Black, Lisa Palermo, et al.. (2007). Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis. Osteoporosis International. 18(7). 973–979. 23 indexed citations

10.

Bauer, Douglas C., Patrick Garnero, John P. Bilezikian, et al.. (2006). Short-Term Changes in Bone Turnover Markers and Bone Mineral Density Response to Parathyroid Hormone in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1370–1375. 94 indexed citations

11.

Black, Dennis M., John P. Bilezikian, Kristine E. Ensrud, et al.. (2005). One Year of Alendronate After One Year of Parathyroid Hormone (1???84) for Osteoporosis. Obstetrical & Gynecological Survey. 61(1). 34–35. 52 indexed citations

12.

Greenspan, S. L., Neil M. Resnick, & Robert A. Parker. (2005). Vitamin D Supplementation in Older Women. The Journals of Gerontology Series A. 60(6). 754–759. 21 indexed citations

13.

Solomon, Daniel H., Clifford J. Rosen, Bess Dawson‐Hughes, et al.. (2003). Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England. Osteoporosis International. 14(2). 123–129. 29 indexed citations

14.

Whitson, Heather E., et al.. (2002). Uncoupling of Bone Turnover Following Hip Replacement. Calcified Tissue International. 71(1). 14–19. 7 indexed citations

15.

Ferrari, Serge, et al.. (2001). A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis & Rheumatism. 44(1). 196–201. 86 indexed citations

16.

Rosen, Harold N., A C Moses, Jeffrey R. Garber, et al.. (2000). Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes with Bisphosphonate Therapy. Calcified Tissue International. 66(2). 100–103. 237 indexed citations

17.

Tollin, Steven R., et al.. (1996). Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia--a Clinical Research Center study.. The Journal of Clinical Endocrinology & Metabolism. 81(3). 1031–1034. 22 indexed citations

18.

Rosen, Harold N., Steven R. Tollin, R. Balena, et al.. (1995). Differentiating between orchiectomized rats and controls using measurements of trabecular bone density: A comparison among DXA, Histomorphometry, and peripheral quantitative computerized tomography. Calcified Tissue International. 57(1). 35–39. 75 indexed citations

19.

Rosen, Harold N., et al.. (1994). Subregion analysis of the rat femur: A sensitive indicator of changes in bone density following treatment with thyroid hormone or bisphosphonates. Calcified Tissue International. 55(3). 173–175. 8 indexed citations

20.

Rosen, Harold N., et al.. (1994). Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcified Tissue International. 54(1). 26–29. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact